dna
vaccin
tremend
potenti
treat
prevent
numer
diseas
tradit
vaccin
ineffect
techniqu
limit
low
immunogen
current
synthet
dna
deliveri
system
versatil
safe
substanti
less
effici
virus
novel
multicompon
supramolecular
system
involv
prepar
mannosebear
chitosan
oligom
microspher
entrap
complex
dna
vaccin
polyethylenimin
develop
mimic
mani
benefici
properti
virus
deliveri
intramuscular
immun
balbc
mice
microspher
induc
enhanc
serum
antibodi
respons
two
order
magnitud
greater
nake
dna
vaccin
addit
contrast
nake
dna
microspher
induc
potent
cytotox
lymphocyt
respons
low
dose
consequ
formul
dna
vaccin
multicompon
vector
power
mean
increas
vaccin
potenc
r
immun
dna
vaccin
result
humor
cellular
immun
respons
protect
diseas
preclin
model
infecti
diseas
cancer
autoimmun
intramuscular
im
inject
primari
rout
administr
dna
vaccin
shown
elicit
protect
therapeut
immun
respons
mani
anim
model
howev
optim
antibodi
cytotox
lymphocyt
ctl
respons
induc
high
dose
dna
nonhuman
primat
human
volunt
although
difficult
quantit
amount
plasmid
dna
enter
cell
degrad
enter
nucleu
initi
gene
express
believ
dna
inject
never
get
cytoplasm
enter
cell
enter
nucleu
gene
express
occur
lower
bioavail
may
due
major
cellular
barrier
plasma
endolysosom
nuclear
membran
nucleas
degrad
vivo
fact
dna
overal
net
neg
electrostat
charg
although
use
dna
vaccin
high
dose
feasibl
would
impos
seriou
limit
number
construct
could
includ
vaccin
addit
use
high
dose
dna
less
favor
process
econom
standpoint
therefor
clear
need
induc
effect
immun
human
lower
fewer
dose
dna
well
increas
magnitud
immun
respons
obtain
number
strategi
avail
potenti
improv
potenc
dna
vaccin
sever
group
attempt
improv
deliveri
use
cation
microparticl
chitosan
nonion
block
copolym
cation
liposom
although
approach
success
far
ideal
gene
deliveri
complic
achiev
singl
carrier
molecul
virus
evolv
parallel
host
employ
gene
therapi
clinic
trial
incred
gene
deliveri
effici
howev
proven
immunogen
promis
direct
would
develop
safer
deliveri
vector
would
mimic
key
properti
virus
multicompon
polym
compon
perform
viral
function
design
novel
mannosebear
chitosan
oligom
mbco
microspher
entrap
polyethylenimin
pei
dna
complex
mimic
benefici
properti
virus
dna
condens
virus
nucleic
acid
protect
protein
coat
capsid
form
hollow
symmetr
structur
enclos
coil
genet
materi
core
microspher
polyc
pei
capabl
induc
dna
condens
convers
filiform
molecul
compact
particl
improv
chemic
stabil
physic
properti
ii
cell
entrytarget
enter
host
virus
divert
function
cellmatrix
cellcel
anchor
protein
heparin
sulfat
proteoglycan
hspg
integrin
respons
cell
entri
receptormedi
endocytosi
condens
dna
particl
also
requir
specif
surfac
cell
entri
dna
vaccin
activ
tcell
respons
requir
present
antigen
profession
antigen
present
cell
apc
shown
number
group
present
inde
occur
profession
bone
marrowderiv
apc
rather
transfect
muscl
cell
approach
surfac
microspher
respons
bind
entri
apc
decid
conjug
mannos
surfac
microspher
apc
dendrit
cell
dc
express
high
level
mannos
receptor
mannoserel
receptor
use
endocytosi
phagocytosi
varieti
antigen
expos
mannos
fucos
residu
iii
endosom
escap
intern
dna
microspher
must
escap
form
intracellular
vacuol
virus
fuse
plasma
membran
exploit
endosom
acid
escap
signal
mean
sophist
conform
chang
fusion
protein
mbco
microspher
pei
share
abil
buffer
acid
endosom
vacuolar
ph
therefor
decreas
slowli
larg
concomit
ionic
concentr
increas
osmot
swell
due
water
entri
may
burst
parvacuol
releas
complex
cytoplasm
famou
proton
spong
hypothesi
prepar
character
microspher
administ
experiment
anim
immun
respons
induc
compar
immun
nake
dna
signific
improv
immunogen
nake
dna
achiev
ctl
antibodi
induct
mbco
microspher
technolog
offer
improv
way
deliv
dna
vaccin
nucleu
cell
mimick
virus
abil
kda
pei
branch
nabh
cn
nano
mannobios
chitosan
mw
kda
deacetyl
purchas
sigmaaldrich
reagent
use
highest
puriti
avail
hbv
plasmid
cmv
promot
kb
plasmid
cmv
promot
kb
plasmid
cmv
promot
kb
construct
lab
obtain
transform
escherichia
coli
strain
cultur
defin
growth
condit
plasmid
purifi
use
qiagen
plasmid
giga
kit
final
product
endotoxin
free
unitsmg
permiss
anim
work
obtain
laboratori
anim
ethic
committe
jilin
univers
china
mannosebear
chitosan
mchitosan
obtain
reduct
amin
mannobios
describ
detail
elsewher
purifi
mannosebear
chitosan
chemic
treat
sodium
nitrit
acet
acid
min
produc
chitosan
oligom
lower
molecular
weight
accord
method
describ
peniston
oligom
purifi
lyophil
use
without
modif
degre
substitut
mannonsyl
unit
chitosan
obtain
elementari
analysi
distortionless
enhanc
polar
transfer
dept
c
nmr
water
solubl
mannosebear
chitosan
oligom
estim
use
transmitt
chitosan
deriv
solut
mbco
microspher
prepar
follow
report
aral
akbuga
slight
modif
briefli
peidna
complex
prepar
character
support
inform
ad
mm
sodium
sulfon
solut
mixtur
quickli
drop
mannosebear
chitosan
oligom
solut
vortex
form
microspher
wash
deioniz
water
separ
centrifug
freezedri
size
distribut
mbco
microspher
determin
dynam
light
scatter
dl
zetas
hs
malvern
instrument
uk
valu
calcul
volum
measur
load
level
dna
microspher
determin
assay
supernat
centrifug
measur
dna
absorb
nm
encapsul
effici
microspher
calcul
zeta
potenti
microspher
measur
apparatu
dl
select
batch
microspher
evalu
transmiss
electron
microscopi
tem
atom
forc
microscopi
afm
size
shape
afm
imag
microspher
taken
nanoscop
iiia
afm
multimod
digit
instrument
santa
barbara
ca
ambient
condit
afm
oper
tap
mode
optic
readout
use
si
n
cantilev
nanoprob
digit
instrument
replac
mannosebear
chitosan
oligom
chitosan
mchitosan
chitosan
mchitosan
microspher
encapsul
pei
dna
prepar
method
mbco
mocrospher
vitro
releas
studi
dna
mbco
microspher
carri
suspend
mg
microspher
ml
fb
ph
mm
nacl
mm
kcl
mm
pb
fc
stir
predetermin
time
interv
suspens
centrifug
replac
volum
fresh
medium
dna
concentr
supernat
determin
uv
absorb
nm
experi
perform
triplic
releas
profil
chitosan
mchitosan
microspher
encapsul
peidna
perform
control
accord
oper
initi
burst
releas
dna
vaccin
microspher
favor
vaccin
vitro
burst
releas
studi
dna
mbco
microspher
carri
cell
simian
viru
kidney
cell
african
green
monkey
use
gfp
report
gene
cell
grown
humidifi
air
contain
co
passag
everi
day
cell
per
well
plate
tissuecultur
plate
h
use
immedi
initi
experi
medium
remov
well
cell
wash
dmem
without
serum
antibiot
treat
dilut
mbco
mchitosan
chitosan
microspher
gfp
express
directli
view
fluoresc
microscop
olympu
america
vivo
releas
dna
mbco
microspher
carri
balbc
mice
bred
care
anim
facil
vaccin
center
jilin
univers
changchun
three
group
femal
balbc
mice
n
inject
either
mg
pcmvluc
dna
mchitosan
microspher
contain
mg
pcmvluc
dna
mbco
microspher
contain
mg
pcmvluc
dna
three
group
mice
inject
im
anterior
tibiali
ta
muscl
one
leg
muscl
mous
harvest
either
day
day
store
freezer
muscl
ground
mortar
pestl
dri
ice
powder
muscl
collect
eppendorf
tube
ml
report
lysi
buffer
freezethaw
three
time
sampl
spun
rpm
min
twenti
microlit
supernat
assay
use
luciferas
assay
normal
total
content
sampl
cell
murin
monocytemacrophag
cell
cultur
dmem
medium
contain
gln
supplement
heatedinactiv
fc
gibco
antibiot
unitsml
penicillin
mgml
streptomycin
sigma
cell
per
well
plate
tissuecultur
plate
h
transfect
immedi
initi
transfect
experi
medium
remov
well
cell
wash
dmem
without
serum
antibiot
treat
serial
dilut
mbco
mchitosan
chitosan
microspher
competit
assay
carri
confirm
uptak
mbco
microspher
mediat
mannosereceptor
ad
mm
mannos
mbco
microspher
suspens
transfect
lipofectamin
tm
complex
perform
posit
control
accord
manufactur
protocol
luciferas
gene
express
monitor
h
later
use
commerci
kit
promega
transfect
experi
perform
triplic
express
mean
light
unit
per
mg
cell
femal
balbc
mice
group
immun
either
mbco
microspher
nake
dna
control
pb
differ
dose
immun
protocol
perform
week
sera
sampl
collect
mice
tail
bleed
differ
time
point
hbsag
specif
serum
igg
titer
confirm
enzymelink
immunosorb
assay
elisa
spleen
immun
mice
harvest
week
fourth
immun
use
pool
five
spleen
cell
cultur
rmpi
phenol
redfre
medium
approxim
target
cell
sensit
synthet
epitop
peptid
concentr
mm
h
cytotox
measur
standard
lactat
dehydrogenas
ldh
releas
assay
ctl
kit
promega
accord
instruct
provid
manufactur
hbsagspecif
cell
spleen
also
indirectli
determin
use
cytokin
enzymelink
immunosorb
spot
elispot
measur
hbsag
induc
ifng
product
perform
accord
instruct
murin
ifng
elispot
kit
bd
usa
mean
sd
obtain
student
ttest
conduct
analyz
differ
pvalu
less
consid
statist
signific
produc
lowmolecularweight
chitosan
random
depolymer
mchitosan
averag
molecular
weight
kda
tabl
studi
pei
dna
complex
encapsul
chitosan
mchitosan
mbco
microspher
tabl
dl
measur
mbco
microspher
show
unimod
particl
size
distribut
nm
zeta
potenti
mbco
microspher
approxim
mv
ph
close
neutral
ph
low
surfac
potenti
mbco
microspher
suitabl
use
vivo
due
low
reaction
compon
vivo
milieu
mbco
microspher
obtain
condit
appear
fairli
spheric
polydispers
natur
reveal
tem
afm
imag
fig
vitro
releas
dna
mbco
microspher
show
initi
burst
releas
first
day
peidna
complex
releas
mbco
microspher
obviou
releas
detect
chitosan
mchitosan
microspher
first
day
molecular
weight
chitosan
chitosan
deriv
significantli
affect
drug
releas
fig
vitro
burst
releas
abil
mbco
microspher
also
evalu
cell
use
pegfp
plasmid
experi
observ
higher
tabl
characterist
chitosan
mannosebear
chitosan
mchito
depolymer
mannosebear
chitosan
dmchito
highest
ph
dissolv
polym
ph
polym
solut
n
hcl
adjust
ad
stepwis
n
naoh
polym
consid
insolubl
one
transmitt
polym
solut
lower
compar
control
solut
n
hcl
data
express
n
percentag
transfect
cell
produc
higher
amount
transgen
product
mbco
fig
microspher
chitosan
fig
mchitosan
fig
microspher
faster
releas
rate
seem
entir
appropri
given
evid
dc
die
within
day
activ
migrat
drain
lymph
node
vivo
releas
dna
mbco
microspher
detect
express
luciferas
inject
ta
muscl
balbc
mice
level
vivo
express
luciferas
higher
mbco
microspher
nake
dna
chitosan
mchitosan
microspher
day
time
point
fig
uptak
express
nake
plasmid
muscl
cell
may
relat
muscl
physiolog
function
like
via
receptormedi
event
involv
tubul
caveola
nake
dna
peak
level
gene
express
muscl
found
day
chitosan
mchitosan
mbco
microspher
peak
level
gene
express
found
day
postinject
possibl
explain
control
releas
dna
mbco
microspher
base
chitosan
oligom
dissoci
easili
highmolecularweight
chitosan
microspher
easili
dissoci
microspher
mediat
faster
onset
action
gave
higher
gene
express
im
administr
vivo
vitro
transfect
effici
mbco
microspher
evalu
cell
use
pcmv
luciferas
plasmid
cell
wellknown
model
cell
monocytemacrophag
cell
rich
mannos
receptor
cell
surfac
result
luminesc
assay
detect
luciferas
activ
transfect
cell
indic
rel
high
transfect
effici
fig
express
luciferas
activ
mbco
three
order
magnitud
higher
background
level
dna
transfect
five
ten
time
lower
lipofectamin
tm
express
activ
chitosan
mchitosan
microspher
tenfold
lower
mbco
microspher
show
slight
transfect
effici
furthermor
decreas
transfect
activ
addit
superflu
mannos
demonstr
mbco
microspher
might
intern
endocytosi
phagocytosi
via
recognit
mannos
receptor
surfac
macrophag
fig
though
mous
bone
marrowderiv
dc
show
rel
lower
mannos
receptor
level
human
dc
mous
conveni
model
dnabas
immun
formul
mbco
microspher
enhanc
antibodi
respons
hbsag
protein
nake
dna
time
point
fig
extens
doserespons
titrat
assess
elisa
nake
dna
prime
hbsagspecif
antibodi
respons
four
continu
dose
dna
high
mg
contrast
mbco
microspher
effect
ng
indic
increas
dna
vaccin
potenc
base
lowest
dose
dna
requir
prime
measur
respons
addit
mbco
microspher
acceler
antibodi
respons
detect
antibodi
respons
hbsag
achiev
within
week
inject
nake
dna
mg
dose
wherea
week
requir
mbco
microspher
dose
acceler
week
statist
signific
clinic
interest
whenev
rapid
immun
respons
critic
hbsagspecif
cell
measur
vitro
assess
death
balb
target
cell
sensit
hbsag
ctl
epitop
peptid
nake
dna
prime
mild
hbsagspecif
cell
highest
dna
dose
mg
wherea
mbco
microspher
effect
dose
low
mg
indic
increas
dna
vaccin
potenc
judg
reduct
dna
vaccin
dose
fig
natur
infect
hbvspecif
cell
ctl
associ
antivir
cytokin
ifng
tnfa
may
play
key
role
viru
resolut
hbsagspecif
cell
measur
vitro
determin
ifng
product
spleen
cell
respons
brief
restimul
ctl
epitop
measur
elispot
fig
mbco
microspher
immun
mg
clearli
correspond
nake
dna
mg
dose
indic
increas
dna
vaccin
potenc
judg
reduct
dna
vaccin
dose
virus
evolv
parallel
human
host
superior
gene
deliveri
system
interest
design
artifici
virus
mimic
aspect
deliveri
system
viru
contain
singl
genet
dna
rna
molecul
coat
specif
number
capsid
protein
compact
viral
size
nm
monomolecular
stoichiometri
size
addit
transfect
abil
golden
criteria
artifici
virus
littl
doubt
viral
characterist
incorpor
nonvir
vector
enhanc
deliveri
effici
necessari
deliveri
system
futur
must
viruslik
particl
instead
understand
incorpor
extrem
effici
mechan
infect
virus
dna
deliveri
system
viruslik
function
necessarili
shapejust
aviat
system
mimic
function
bird
alway
morpholog
base
previou
studi
ideal
artifici
viru
system
possess
follow
properti
eas
assembl
effici
deliveri
lead
total
transfect
stabil
dna
uptak
capabl
travers
presum
barrier
gene
deliveri
eg
incorpor
viral
compon
mimick
viral
characterist
effici
decomplex
unpackag
eg
intracellular
control
releas
effici
nuclear
target
current
nonvir
system
properti
biopolym
provid
versatil
chemistri
wide
varieti
differ
function
addit
rel
cheap
produc
biopolym
excel
candid
construct
artifici
virus
studi
design
novel
mbco
microspher
special
address
desir
characterist
mannosebear
chitosan
oligom
chosen
inert
coat
enclos
dna
vaccin
chitosan
propos
nontox
biodegrad
polycation
polym
extens
record
safe
use
gene
deliveri
system
studi
commerci
avail
chitosan
highmolecular
weight
kda
use
unfortun
chitosan
biodegrad
slowli
delay
releas
dna
anoth
pharmaceut
drawback
low
solubl
physiolog
ph
viscosityenhanc
properti
concentr
suitabl
vivo
gene
therapi
therefor
produc
lowmolecular
weight
version
averag
molecular
weight
kda
chitosan
random
depolymer
chitosan
tabl
easili
dissoci
chitosan
oligom
gave
higher
gene
express
cell
vitro
compar
stabl
highmolecular
weight
chitosan
fig
addit
mbco
microspher
induc
higher
luciferas
express
vivo
stabl
highmolecular
weight
chitosan
microspher
day
time
point
vitro
vivo
data
suggest
dissoci
chitosan
oligom
microspher
fast
process
releas
dna
microspher
subsequ
onset
action
compar
biodegradationdepend
releas
addit
coval
attach
mannos
primari
amin
function
chitosan
target
apc
intern
via
recognit
mannos
receptor
surfac
apc
mf
fig
mechan
adjuv
effect
achiev
mbco
microspher
current
known
believ
effici
deliveri
apc
may
import
contribut
factor
ii
core
mbco
microspher
polyc
pei
capabl
induc
dna
condens
pei
use
gene
oligonucleotid
transfer
cell
cultur
vivo
howev
rapid
inactiv
due
undesir
interact
compon
vivo
milieu
polyc
gener
less
immunogen
virus
howev
activ
innat
defens
mechan
major
problem
complement
system
activ
pei
demonstr
highli
posit
complex
activ
stimul
current
studi
activ
complement
cascad
might
avoid
shield
posit
particl
mannosebear
chitosan
oligom
tabl
addit
pei
possess
abil
buffer
acid
endosom
abl
escap
base
proton
spong
hypothesi
former
chitosanbas
system
ineffici
releas
endosom
cytoplasm
caus
low
transfect
effici
system
synergist
effect
transfect
effici
clearli
observ
combin
use
chitosan
pei
data
shown
henc
mbco
microspher
mimic
follow
five
desir
characterist
viru
dna
condens
ii
cell
entrytarget
iii
endosom
escap
iv
compact
viral
size
nm
v
effici
decomplex
biopolymerbas
artifici
virus
potenti
becom
highli
effici
versatil
safe
dna
vaccin
vector
may
replac
recombin
virus
standard
vehicl
genet
vaccin
howev
must
first
engin
polym
improv
deliveri
gene
outsid
target
cell
nucleu
genet
vaccin
vector
futur
construct
much
like
virus
mulitifunct
supramolecular
system
selfassembl
around
dna
compon
perform
function
imit
viral
characterist
studi
demonstr
mbco
microspher
potent
deliveri
system
dna
vaccin
capabl
induc
enhanc
humor
cellular
respons
im
immun
hbsag
plasmid
anoth
key
advantag
system
speed
immun
induct
recent
year
outbreak
ebola
viru
sever
acut
respiratori
syndrom
influenza
caus
concern
convent
dna
vaccin
strategi
slow
induc
immun
studi
serv
highlight
excit
potenti
mulitifunct
supramolecular
system
method
induct
rapid
immun
respons
dna
vaccin
subsequ
studi
sever
new
biomateri
design
overcom
specif
import
gene
deliveri
barrier
enhanc
need
reach
gene
deliveri
effici
obtain
virus
result
encourag
ultim
technolog
hold
great
promis
use
human
